Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Chronic stress has been associated with development of several diseases and the release of several cytokines and growth factors known to support cancer growth and metastases. Pharmacological agents targeting the stress response, such as beta-blockers and prostaglandin inhibitors, have been associated with improved survivorship in patients with several solid tumors, including ovarian cancer. The relationship supports prospective clinical investigation, already underway.

Stress and Poor Cancer Outcomes: It’s More Than Psychological